Member Info for MIKODX

Yes it has been. Fundamentals have improved, which in turn has reinforced sentiment. The recent board changes has also improved governance and investor confidence. This has been steadily creeping up for the last two weeks. If revenue continues to improve, the tick up could continue for a while yet, which will be great for the company and shareholders too. Onwards & Up.

The stroke test was always going to be the real winner out of the two. The stroke market is a considerably bigger market than the hearing test. The signs so far are positive with adoption taken up by a number of key NHS sites. This is going to be a big year for Genedrive, the stroke test is going to be the game changer. I see demand outstripping supply when they see the benefits of this groundbreaking technology.

No chance here with this stock, thats for sure.

Happy New Year.

No one knows the exact date of the court hearing, but it will be happening in Q1 26. In fact the whole deal including shareholder payouts should be wrapped up in Q1, Q2 if any delays.

It’s not good watching the SP slowly slip down, but that’s bound to happen with no positive news. The one consolation is the support at 5.70 is holding up well so far. Hopefully we can kick off the new year with some good news and hopefully get a good bounce from the support level all the way up past 10.

Well almost guaranteed, same difference lol.

Weighed up the risk and decided to top up with a substantial amount. It’s a guaranteed 25% as the deal is as good as complete now, so I thought why not. It does come with risk of course but that’s what happens with investments, they always come with some type of risk. The risk with this particular stock is not that great and the reward is decent. I just hope now the deal is just a formality. Will be an interesting first quarter next year that’s for sure.

Might top up some more next week, we'll see. Already multibagged here, Bought in la.st month again, and already 20% up. Great stock to be invested in.

FY2025 was a key year for the company in establishing a solid pathway for testing adoption, life science services and strategic partnering. In July 2025, RENX announced an agreement with MVP Health Care, a U.S.-based insurer covering more than 700,000 patients. Beyond expanding physician and patient access, this agreement reinforces that Renalytix and kidneyIntelX.dkd are establishing a leadership position in chronic kidney disease management and gaining increasing recognition in the market.

In September 2025, Renalytix signed an agreement with Tempus AI, Inc. (“Tempus”), a clear leader in delivery of integrated advanced diagnostic testing and life science services in the United States. The collaboration with Tempus will enable RENX to accelerate introduction of kidneyintelX.dkd into large hospital systems and community healthcare practices across the U.S., significantly expanding distribution over the next five years. The relationship with Tempus AI has continued to develop positively, with ongoing progress in aligning commercial activities.

The Balance Sheet was further improved with the conversion of an additional $4 million of convertible debt leaving outstanding long-term debt at £3.1m as of October 2025. More than $1.3m in cash from backdated R&D claims and grant income, further strengthening the balance sheet. Administrative expenses decreased by more than 40% year-on-year, driven by headcount and operations optimization. RENX continue to strengthen there presence in three initial target states - Florida, Texas, and New York. In FY26, they expanded into Arizona their fourth target market which collectively represents approximately 20% of the total addressable kidneyintelX.dkd market. RENX is well positioned to deliver important and necessary change in chronic kidney disease management in the United States and globally.In the coming months and years sales will without doubt improve with the test being made more readily available in healthcare systems.

Not been a bad year for the company, quite the opposite, it has been a very positive one. FY26 will see the partnerships coming to fruition with the test more widely available in the healthcare systems which will mean more sales for the company. Lots to look forward to in the coming year. I'll drink to that.

Hope everyone has a merry xmas and the best of luck for the new year. With any luck we will have some good news from the parterships established, which will have a very positive affect on the SP. As we all know, this is a very volatile stock that can really take off on good news. Next year will be the year.

GLA

I don't see what more he can do. His contribution to the cause shows that he has real belief in the company and more importantly, shows he cares. The company surely have to get him on board now, if it's even just as a NED. His appointment in any capacity would give the SP a lift, as would any positive news around funding.

Just joined up.

Check the amount of shares they have issued, that alone should tell you the state of this company. All they do is rinse shareholders and devalue the stock with constant dilution. If your looking to earn on your investment, you'd do well to look elsewhere. Complete sh..show over here.

Well if anyone came in with a 10M offer, the board would be forced to consider especially with the way finances are with the company.

Need some good news to get the SP moving. With a higher SP only then would it make sense to do a fundraise, with dilution having minimum impact to shareholders, and add value to the company.

TrollHunter2 - Has to be the biggest troll on here with a comment like that. How he can blindly ignore how this company is behaving beggars belief. Anyone that listens to a word he says needs to get their heads checked.

Unfortunately got stuck in this pile of s... looking to make a quick buck and get the hell out. I knew his was a badly run company just by the number of shares they held. But silly me thought I could get in and out in time only for a dilution to happen as soon as I invested. Fortunately I didnt invest a lot as I knew this was a high risk stock. Looks like I was proved right, just glad I didnt put too much into it. Another lesson learned. It's the long term holders I feel sorry for. There shares must be worth virtually zero.

Another dilution of 3B shares to raise a potsy 0.5M. If investors were so interested in investing in this company they would buy up the shares not invest by way of fundraise. All that means is they bought a sackful of shares on the cheap and devalued the company further. This company is absolute pants and dont give a f... about shareholders, it's plain to see. Diluting shares at every opportunity is the sign of a badly run company whose sole intention is to take shareholders to the cleaners. Disgusting.

London stocks had tumbled by midday on Friday, with sterling weaker amid reports that Chancellor Reeves will ditch plans to raise income tax at the upcoming Budget, while fading hopes of a US December rate cut and worries about an AI bubble also dented the mood.

The FTSE 100 was 1.8% lower at 9,627.95 , while the pound was down 0.3% against the dollar at 1.3149 .

I've been here since April at 42p. Great share to be in. Well done to all those winning. We take our losses on the chin, so only right we celebrate when we're winning. Good luck to all invested.

Th y would have to formally announce that they intend to go into administration if they intend to cease trading.